Andrew M, Mitchell L, Vegh P, Ofosu F
Department of Pediatrics, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Thromb Haemost. 1994 Dec;72(6):836-42.
The physiologic mechanisms that protect children from thromboembolic complications are not known. We investigated the regulation of thrombin in children because of its central importance to thrombosis. The capacity to generate thrombin in vitro (chromogenic assay) was decreased by 26% in plasmas from children (1-16 yrs; n = 102) compared to adults ([20-45 yrs; n = 20; p < 0.001]). The addition of purified prothrombin to plasmas from children increased thrombin generation to adult values. The capacity of plasmas to inhibit 125I-alpha-thrombin was increased by 21% in children compared to adults (p = 0.020), with significantly more thrombin complexed to alpha 2-macroglobulin (alpha 2M) in children. When DVT occur in children, adult guidelines for heparin therapy are used. At low heparin concentrations (0.1 and 0.2 U/ml), thrombin generation was decreased by 30% in children compared to adults (p < 0.001). At high heparin levels (0.4 U/ml), thrombin generation was negligible in all plasmas. ATIII inhibited over 95% of thrombin in all plasmas in the presence of heparin. In summary, thrombin regulation differs in children from adults and may protect children from thromboembolic complications. When DVT do occur, heparin requirements may differ in children compared to adults.
保护儿童免受血栓栓塞并发症影响的生理机制尚不清楚。由于凝血酶在血栓形成中至关重要,我们对儿童凝血酶的调节进行了研究。与成人([20 - 45岁;n = 20;p < 0.001])相比,儿童(1 - 16岁;n = 102)血浆中体外生成凝血酶的能力(发色底物法)降低了26%。向儿童血浆中添加纯化的凝血酶原可使凝血酶生成增加至成人水平。与成人相比,儿童血浆抑制125I-α-凝血酶的能力增加了21%(p = 0.020),儿童中与α2-巨球蛋白(α2M)结合的凝血酶明显更多。当儿童发生深静脉血栓形成(DVT)时,采用成人肝素治疗指南。在低肝素浓度(0.1和0.2 U/ml)下,与成人相比,儿童的凝血酶生成降低了30%(p < 0.001)。在高肝素水平(0.4 U/ml)下,所有血浆中的凝血酶生成可忽略不计。在肝素存在的情况下,抗凝血酶III(ATIII)抑制了所有血浆中超过95%的凝血酶。总之,儿童与成人的凝血酶调节不同,这可能保护儿童免受血栓栓塞并发症的影响。当确实发生DVT时,儿童与成人的肝素需求可能不同。